1217366-74-9 Usage
Uses
Used in Pharmaceutical Research:
4-(4-Bromo-3-(1,3-dioxolan-2-yl)phenoxy)benzonitrile is used as a building block for the synthesis of novel compounds in pharmaceutical research, contributing to the development of new drugs for various therapeutic areas.
Used in Oncology:
In the field of oncology, 4-(4-Bromo-3-(1,3-dioxolan-2-yl)phenoxy)benzonitrile is used as a potential component in the development of anticancer drugs, targeting the synthesis of compounds that can combat cancer cells.
Used in Neurology:
4-(4-Bromo-3-(1,3-dioxolan-2-yl)phenoxy)benzonitrile is utilized in neurology for the synthesis of compounds that may have therapeutic effects on neurological disorders, potentially leading to new treatments for such conditions.
Used in Antimicrobial and Antifungal Applications:
4-(4-BroMo-3-(1,3-dioxolan-2-yl)phenoxy)benzonitrile is studied for its potential antimicrobial and antifungal properties, suggesting its use in the development of new agents to combat microbial infections and fungal diseases.
Used in Agrochemical Development:
Due to its unique structure and properties, 4-(4-Bromo-3-(1,3-dioxolan-2-yl)phenoxy)benzonitrile may be used in the development of agrochemicals, potentially contributing to the creation of new pesticides or other agricultural chemicals.
Used in Materials Science:
4-(4-BroMo-3-(1,3-dioxolan-2-yl)phenoxy)benzonitrile's unique properties also make it a candidate for use in materials science, where it could be employed in the development of new materials with specific characteristics for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1217366-74-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,7,3,6 and 6 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1217366-74:
(9*1)+(8*2)+(7*1)+(6*7)+(5*3)+(4*6)+(3*6)+(2*7)+(1*4)=149
149 % 10 = 9
So 1217366-74-9 is a valid CAS Registry Number.
1217366-74-9Relevant academic research and scientific papers
Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis
Akama, Tsutomu,Baker, Stephen J.,Zhang, Yong-Kang,Hernandez, Vincent,Zhou, Huchen,Sanders, Virginia,Freund, Yvonne,Kimura, Richard,Maples, Kirk R.,Plattner, Jacob J.
scheme or table, p. 2129 - 2132 (2009/12/07)
A series of phenoxy benzoxaboroles were synthesized and screened for their inhibitory activity against PDE4 and cytokine release. 5-(4-Cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole (AN2728) showed potent activity both in vitro and in vivo. This compound is now in clinical development for the topical treatment of psoriasis and being pursued for the topical treatment of atopic dermatitis.
